Securities Code: 002551
Securities Abbreviation: Rong Medical
Announcement No.: 2026-017
Shenzhen Rong Medical Co., Ltd.
Announcement on Progress of Subsidiary Arbitration Case
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Special Reminders:
-
Arbitration Stage: Final Award.
-
Party Status of the Listed Company (Shenzhen Rong Medical Co., Ltd. (hereinafter referred to as the "Company")'s subsidiary, Glory Medical Co. Ltda. Sucursal del Perú, hereinafter referred to as the "Peruvian Subsidiary" or "Applicant")): Applicant.
-
Amount Involved: The award orders PRONIS (Programa Nacional de Inversiones en Salud, hereinafter referred to as "PRONIS" or "Respondent") to return to the Peruvian Subsidiary: (1) the amount of S/9,247,000.00 (Nine Million Two Hundred Forty-Seven Thousand Soles) and interest due to improper execution of a guarantee; (2) payment and bearing of costs for engineering progress, direct costs of mechanical installation work performed, and materials purchased but not used for project execution totaling S/484,463.15 (Four Hundred Eighty-Four Thousand Four Hundred Sixty-Three Soles and Fifteen Cents); (3) the balance after deducting the direct advance payment guarantee and the first material advance payment guarantee totaling S/15,047,919.43 (Fifteen Million Forty-Seven Thousand Nine Hundred Nineteen Soles and Forty-Three Cents) from the contract settlement amount, plus corresponding legal interest (this returned amount needs to be determined upon contract settlement, and this amount is uncertain); (4) compensation of 50% of the expected profit for the unexecuted remaining works (this amount will be determined based on the settlement results according to Peruvian regulations); (5) payment of legal defense fees incurred by the Peruvian Subsidiary of US$75,225.00 (Seventy-Five Thousand Two Hundred Twenty-Five US Dollars); (6) bearing 75% of the costs stipulated by the "Arbitration Law," with the Peruvian Subsidiary bearing 25% of these costs.
-
Impact on the Listed Company's Profit and Loss: Given that the Company has fully accrued impairment provisions for expenses related to this project, the above amounts, upon receipt, will offset the related impairment provisions and expenses that have been accrued, and will increase the income of the period in which the collection occurs.
The Peruvian Subsidiary recently received an "Arbitration Award" (Arbitration Case No. 5050-657-23) issued by the Center for Analysis and Resolution of Conflicts of the Pontifical Catholic University of Peru (Centro de Análisis y Resolución de Conflictos de la Pontificia Católica del Perú), the contents of which are as follows:
I. Basic Situation of the Acceptance of the Major Arbitration Case